Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
12%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
XBI
122
HOLDINGS
12%
ALSO IN IBRN
IBRN
60
HOLDINGS
36%
ALSO IN XBI
SECTOR DRIFT (XBI minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 1.9% | 3.9% | 1.9% |
|
BIOGEN IDEC INC | 1.8% | 3.9% | 1.8% |
|
PTC THERAPEUTICS INC | 1.4% | 4.1% | 1.4% |
|
SCHOLAR ROCK HOLDING CORP. | 1.3% | 4.9% | 1.3% |
 |
ALKERMES PLC | 1.2% | 3.7% | 1.2% |
XBI Overweight Relative to IBRN
|
CRISPR THERAPEUTICS AG | 2.2% |
|
UNITED THERAPEUTICS CORP | 2.0% |
|
ABBVIE INC | 1.9% |
|
EXELIXIS INC | 1.9% |
|
REGENERON PHARMACEUTICALS | 1.9% |
|
MODERNA, INC. | 1.9% |
|
IONIS PHARMACEUTICALS, INC. | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
|
BIOMARIN PHARMACEUTICAL INC | 1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.8% |
XBI Underweight Relative to IBRN
|
SUPERNUS PHARMACEUTICALS INC | -4.1% |
 |
ARGENX SE ADR | -3.8% |
|
AXSOME THERAPEUTICS, INC. | -3.7% |
|
SCHOLAR ROCK HOLDING CORP. | -3.6% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.5% |
|
CATALYST PHARMACEUTICAL PART | -3.0% |
|
PTC THERAPEUTICS INC | -2.7% |
|
ALKERMES PLC | -2.5% |
|
DENALI THERAPEUTICS INC. | -2.5% |
|
ACADIA PHARMACEUTICALS INC | -2.4% |